We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Stylized DNA strand surrounded by nucleotide letters and padlock icons representing genetic data security.
Product News

Watchmaker Genomics and Revvity Team To Automate and Streamline NGS Library Preparation

Watchmaker Genomics has collaborated with Revvity to automate its DNA and RNA library preparation kits for NGS workflows on the Sciclone™ G3 NGSx platform.
Two scientists in a laboratory analyzing data on a computer and tablet beside a microscope.
Product News

Biodesix and Bio-Rad Drive Advances in ctDNA-Based Cancer Therapies

Biodesix, in partnership with Bio-Rad, contributed to the ctMoniTR Project, which demonstrated that changes in circulating tumor DNA (ctDNA) can predict cancer treatment outcomes.
Doctor filling out a diagnostic form on a clipboard while consulting with a patient.
Product News

Cleveland Diagnostics Announces Landmark Longitudinal Study Published in Urology

A new study highlights IsoPSA’s ability to identify low-risk prostate cancer patients who can avoid unnecessary interventions. The test also helps monitor high-risk patients more closely.
Scientist pipetting pink media into a cell culture plate in a sterile lab environment.
Product News

GlymaxX®-Enhanced Antibody Now Commercially Available for Innovative Cancer Therapy

ProBioGen’s GlymaxX technology supports the FDA-approved Ziihera® antibody for HER2-positive biliary tract cancer, advancing targeted therapies.
Cells.
Product News

Seer To Feature Proteomic Advancements in Cancer and RNA Therapy Research Among Other Findings at US HUPO 2025

Seer, Inc. (Nasdaq: SEER), announced that the company will showcase new findings at the 21st Annual US Human Proteome Organization (HUPO) Conference in Philadelphia, PA, from February 22-26, 2025.
An RNA molecule.
Product News

Dovetail Genomics Announces Early Access Service for FFPE Sample Analysis, Enhancing Cancer Research Capabilities

Dovetail Genomics, announces the availability of its early access services for FFPE (Formalin-Fixed Paraffin-Embedded) sample analysis, offering new capabilities for detecting structural variants and profiling RNA in oncology research.
Advertisement